Deferiprone: Iron Stress as a Translational Lever
2026-09-07
Deferiprone is more than an iron-chelation reagent: it is a controlled perturbation tool for mapping how iron availability reshapes proliferation, metabolism, inflammation, oxidative stress, and apoptosis. This article connects enterocyte findings with cancer biology, doxorubicin-response studies, and cerebral vasospasm treatment research while outlining a rigorous workflow for translational experiments.
Roscovitine: A Data-Driven CDK Assay Guide
2026-09-05
Roscovitine (Seliciclib) is a selective CDK probe for connecting biochemical potency with reversible cell-cycle phenotypes. This guide applies a data-driven library-design framework to assay selection, interpretation, and translational validation.
Gepotidacin vs Nitrofurantoin in Uncomplicated UTI
2026-09-05
The EAGLE-2 and EAGLE-3 phase 3 trials evaluated oral gepotidacin, a first-in-class antibiotic with a distinct bacterial topoisomerase mechanism, against nitrofurantoin for uncomplicated urinary tract infection. Gepotidacin met the prespecified non-inferiority criterion in both trials and was superior in EAGLE-3, supporting its potential as an oral option while highlighting the importance of resistance-aware UTI development.
TAK-242 for TLR4 Assay Design
2026-09-04
TAK-242 (Resatorvid) gives researchers a selective way to test how TLR4 drives inflammatory outputs, from LPS-stimulated macrophages to injury-associated neuroinflammation. This practical guide connects cell-based dose finding with seizure, glial, and neuronal readouts while emphasizing controls, solvent handling, and interpretation limits.
Candida krusei Phases Trigger Distinct BMEC Apoptosis
2026-09-04
Miao and colleagues show that the yeast and hypha phases of Candida krusei both induce bovine mammary epithelial cell apoptosis but engage different dominant signaling routes. Their phase-resolved co-culture design links yeast-associated injury to mitochondrial dysfunction and hypha-associated injury to death ligand/receptor signaling, providing a framework for interpreting morphology-dependent host damage in fungal mastitis.
Ginsenosides and High-Altitude Hypoxia Injury
2026-09-03
A 2024 Frontiers in Pharmacology study shows that ginsenosides reduce acute hypoxia-related injury in rat lung and kidney tissues while improving hematological, inflammatory, and oxidative-stress indicators. Its main contribution is linking these protective effects to regulation of the PHD2/HIF-1α/EPO axis, although the findings remain preclinical and model-dependent.
Surface Trafficking with Sulfo-NHS-SS-Biotin
2026-09-03
A translational framework for using cleavable surface biotinylation to distinguish protein abundance from membrane trafficking, anchored in TGEV-infected intestinal epithelial cells and the NHE3–SGLT1 signaling study.
Maternal Surgery, Calpain, and Offspring Cognition
2026-09-02
The reference study identifies excessive calpain activity as a mechanistic link between maternal non-obstetric surgery during pregnancy and later offspring cognitive impairment. In a pregnant rat model, postnatal calpain inhibition partially restored BDNF/TrkB signaling, hippocampal structure, and behavioral performance, providing a pharmacological framework for neuroprotection research.
Cy3 Goat Anti-Human IgG (H+L) Antibody Workflows
2026-09-02
Build sensitive human IgG detection workflows for immunofluorescence, tissue imaging, flow cytometry, and ELISA with a Cy3 conjugated secondary antibody. This practical guide connects assay selection, signal optimization, and orthopoxvirus antibody research while clarifying species-specific limitations.
HyperScript RT SuperMix for qPCR: Assay Strategy
2026-09-01
HyperScript RT SuperMix for qPCR supports reproducible cDNA synthesis for qPCR when RNA is scarce or structurally challenging. Using a hepatocellular carcinoma study as a case study, this article connects reverse-transcription design with biological interpretation, controls, and assay confidence.
Octyl-α-ketoglutarate for HIF-1α Assays
2026-09-01
Use Octyl-α-ketoglutarate as a cell-permeable α-ketoglutarate rescue tool to connect TCA-cycle status with PHD activity and HIF-1α turnover. This workflow separates metabolic causality from nonspecific hypoxia responses in IDH, succinate, fumarate, and colorectal cancer models.
Protein A/G Magnetic Beads for TPM3 IP
2026-08-31
Build low-background IP, co-IP, and PTM workflows around recombinant Protein A and Protein G beads to investigate TPM3, HDAC3, and vascular smooth muscle signaling. Practical starting parameters, controls, and troubleshooting guidance help distinguish true protein interactions from nonspecific recovery.
Protease Inhibitor Cocktail: EDTA-Free Workflow
2026-08-30
Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic loss during cell or tissue lysis and protein-sensitive assays. It is suited to workflows that must preserve divalent cations, but it is not a complete metalloprotease or phosphatase inhibitor system and should be validated for each sample type.
Palonosetron hydrochloride for 5-HT3 Research
2026-08-29
Use Palonosetron hydrochloride as a nanomolar probe for 5-HT3A/5-HT3AB signaling, receptor persistence, and translational antiemetic research. Its longer-lasting pharmacology also supports carefully controlled OCT2 and MATE1 transporter experiments relevant to cancer research.
Glycogen Colorimetric Assay Kit II Workflow
2026-08-29
Build an interference-aware glycogen measurement workflow for muscle, liver, and other biological extracts. This guide connects the Glycogen Colorimetric Assay Kit II to high-throughput exercise, circadian, diabetes, and glycogen storage disease research while emphasizing controls, time-matched sampling, and troubleshooting.
460 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page